Shaping Silver Nanoparticles' Size through the Carrier Composition: Synthesis and Antimicrobial Activity

Area of Science:

• Materials Science
• Nanotechnology
• Microbiology
• Chemistry

Background:

• Antibiotic resistance is a critical global health threat, necessitating novel antimicrobial strategies.
• Silver nanoparticles (AgNPs) exhibit broad-spectrum antibacterial properties, enhanced at the nanoscale.
• Developing effective silver-based nanomaterials for clinical applications is an active area of research.

Purpose of the Study:

• To synthesize and characterize silver nanoparticle (AgNP) hybrids using distinct organic and inorganic supports.
• To investigate the influence of support material on AgNP size and shape.
• To evaluate the antimicrobial efficacy of the resulting AgNP composites against multi-drug-resistant bacteria and Candida albicans.

Main Methods:

• Synthesis of AgNP composites utilizing cellulose nanocrystals (CNC), reduced graphene oxide-salicylic acid (rGO-SA), and titanium dioxide (TiO2) as supports.
• Characterization of AgNPs, focusing on shape and size modulation by the chosen bioactive support.
• Antimicrobial susceptibility testing of AgNP composites against clinically relevant multi-drug-resistant bacterial strains and Candida albicans.

Main Results:

• Successful synthesis of three distinct AgNP hybrid materials on organic (CNC, rGO-SA) and inorganic (TiO2) supports.
• Demonstrated ability to tune AgNP morphology based on the selected support material.
• AgNP composites exhibited significant antimicrobial activity against tested multi-drug-resistant bacteria and Candida albicans.

Conclusions:

• The integration of silver nanoparticles onto selected organic and inorganic supports yields effective antimicrobial composite materials.
• These AgNP-based composites represent a promising avenue for developing new therapeutic agents against resistant pathogens.
• The study highlights the potential of tailored nanomaterial design in addressing the challenge of antimicrobial resistance.